More cutting-edge cancer research supported by industry

May 17, 2012, Fox Chase Cancer Center

Nearly half of the research presented at ASCO's annual meeting last year came from researchers with ties to companies, and the amount appears to be increasing every year, according to new findings from Fox Chase Cancer Center. The new findings will be presented this year at the 2012 American Society of Clinical Oncology Annual Meeting on Monday, June 4.

"The results suggest that there may be an increasing dependence on industry to support cancer research," says study author Angela R. Bradbury, M.D., assistant professor in the Department of at Fox Chase. "This doesn't mean the research is flawed or biased in any way," she cautions, "but it does mean that the professional and research community has to investigate the impact of these relationships and find ways to manage any potential ."

Bradbury and her colleagues reviewed research submitted to the 2011 American Society of Clinical Oncology Annual Meeting, which requires all authors who want to present their findings to state if they have any relationships with industry. This includes being employed by a company, as well as owning stock, serving as a consultant or expert witness, and receiving honoraria for giving talks or participating in .

They found that 48% of research accepted for presentation at the meeting in 2011 came from a group where at least one author had a relationship to industry—up from 39% of research presented in 2006. These ties to industry appeared to increase every year.

Interestingly, in a second related abstract by the same authors, Beverly Moy, M.D., M.P.H., clinical director of the Breast Program and a medical oncologist at the Massachusetts General Hospital, reported that high profile research—selected to be presented more prominently at the meeting—was more likely to come from scientists with relationships to industry. Studies from authors with ties to industry also tended to receive higher scores from their peers.

"This finding doesn't mean that researchers with industry have some 'in' that others don't," says Bradbury. "Rather, it suggests that authors of much of the cutting-edge, clinically important research have relationships with industry."

This is not a surprise, she says, given that other sources of research funding have dried up recently. "We need money for , and it has to come from somewhere. The government has had to cut back on its support, and with the economic crisis research foundations have less money to allocate as well."

But if cancer researchers are going to continue to link up with companies that can profit from their data, the community has to be aware of the potential issues, Bradbury cautions. "If we're going to have relationships with industry, we're going to have to find ways to monitor and manage these relationships, to ensure they don't end up biasing any results."

Given that many great clinicians work with companies, patients shouldn't worry about asking their doctors if they personally have ties to , Bradbury reassures. "Whether or not a doctor has a relationship with a company shouldn't have any impact on patient care," she says.

Explore further: Conflicts of interest plague the next international manual of mental disorders

Related Stories

Conflicts of interest plague the next international manual of mental disorders

March 13, 2012
There are concerns that the revised Diagnostic and Statistical Manual of Mental Disorders (DSM—an internationally recognised classification of mental disorders produced by the American Psychiatric Association), scheduled ...

Recurring cancers in women with a history of breast cancer differ from the original tumors

May 18, 2011
When women with a history of breast cancer learn they have breast cancer again, one of the first questions they and their doctors ask is: Has my cancer come back, or is this a new case? Now, new data from Fox Chase Cancer ...

Most parents who get tested for breast cancer genes share results with their children

January 9, 2012
A new study has found that when parents get tested for breast cancer genes, many of them share their results with their children, even with those who are very young. Published early online in CANCER, a peer-reviewed journal ...

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.